ResearcherJichi Medical UniversityNo recent work listed
Yoshinori Tanaka
Matched on ORCID iD 0000-0003-1428-0683; OpenAlex author ID A5076829080. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2011: 1 paper · 2012: none · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper
Papers 7
- Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome for Pancreatic Cancer Due to Early Diagn… Co-author DOI 10.3390/cancers15030561↗
- Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer. Co-author DOI 10.1097/md.0000000000027591↗
- ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer. Co-author DOI 10.2169/internalmedicine.3748-19↗
- Early Detection of Pancreatic Cancer in Patients With Chronic Liver Disease Under Hepatocellular Carcinoma Surveillance. Co-author DOI 10.1016/j.mayocp.2018.12.034↗
- Efficacy of chemotherapy in elderly patients with unresectable pancreatic cancer: a multicenter review of 895 patients. Co-author DOI 10.1186/s12876-017-0623-8↗
- Improvement of long-term outcomes in pancreatic cancer and its associated factors within the gemcitabine era: a collaborative retrospective multicenter clinica… Co-author DOI 10.1186/1471-230x-13-134↗
- Reduced plasma level of CXC chemokine ligand 7 in patients with pancreatic cancer. Co-author DOI 10.1158/1055-9965.epi-10-0397↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Nobuaki Azemoto · 6 shared papers, 2013–2023 · strength 0.50
- Paper Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome … DOI 10.3390/cancers15030561↗
- Paper Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer. DOI 10.1097/md.0000000000027591↗
- Paper ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer. DOI 10.2169/internalmedicine.3748-19↗
- Yoshinori Ohno · 6 shared papers, 2013–2023 · strength 0.50
- Paper Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome … DOI 10.3390/cancers15030561↗
- Paper Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer. DOI 10.1097/md.0000000000027591↗
- Paper ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer. DOI 10.2169/internalmedicine.3748-19↗
- Mitsuhito Koizumi · 6 shared papers, 2013–2023 · strength 0.50
- Paper Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome … DOI 10.3390/cancers15030561↗
- Paper Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer. DOI 10.1097/md.0000000000027591↗
- Paper ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer. DOI 10.2169/internalmedicine.3748-19↗
- Teru Kumagi · 6 shared papers, 2013–2023 · strength 0.50
- Paper Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome … DOI 10.3390/cancers15030561↗
- Paper Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer. DOI 10.1097/md.0000000000027591↗
- Paper ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer. DOI 10.2169/internalmedicine.3748-19↗
- Taira Kuroda · 6 shared papers, 2013–2023 · strength 0.50
- Paper Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome … DOI 10.3390/cancers15030561↗
- Paper Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer. DOI 10.1097/md.0000000000027591↗
- Paper ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer. DOI 10.2169/internalmedicine.3748-19↗
- Yoichi Hiasa · 6 shared papers, 2013–2023 · strength 0.50
- Paper Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome … DOI 10.3390/cancers15030561↗
- Paper Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer. DOI 10.1097/md.0000000000027591↗
- Paper ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer. DOI 10.2169/internalmedicine.3748-19↗
- Takashi Terao · 5 shared papers, 2017–2023 · strength 0.47
- Paper Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome … DOI 10.3390/cancers15030561↗
- Paper Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer. DOI 10.1097/md.0000000000027591↗
- Paper ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer. DOI 10.2169/internalmedicine.3748-19↗
- Hiroshi Ishii · 2 shared papers, 2019–2020 · strength 0.16
- Ichinosuke Hyodo · 1 shared paper, 2021 · strength 0.11
- Masanori Abe · 2 shared papers, 2013–2020 · strength 0.11
- Morikazu Onji · 1 shared paper, 2013 · strength 0.03
- Shoji Nakamori · 1 shared paper, 2011 · strength 0.02
- Michimoto Kobayashi · 1 shared paper, 2011 · strength 0.02
- Tomoo Kosuge · 1 shared paper, 2011 · strength 0.02
- Tsutomu Chiba · 1 shared paper, 2011 · strength 0.02
- Tatsuya Ioka · 1 shared paper, 2011 · strength 0.02
- Naohiro Sata · 1 shared paper, 2011 · strength 0.02
- Junichi Matsubara · 1 shared paper, 2011 · strength 0.02
- Akihiko Tsuchida · 1 shared paper, 2011 · strength 0.02
- Tesshi Yamada · 1 shared paper, 2011 · strength 0.02
- Takuji Okusaka · 1 shared paper, 2011 · strength 0.02
- Kazufumi Honda · 1 shared paper, 2011 · strength 0.02
- Giman Jung · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.